Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3-4

International Urology and Nephrology

Volumn 42, Issue 4, 2010, Pages 1055-1062

  Gulati, Ashima ^a   Sridhar, Vijesh ^a   Bose, Tathagata ^a   Hari, Pankaj ^a   Bagga, Arvind ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Calcium phosphate product; CKD mineral and bone disorder; Hyperphosphatemia; Sevelamer hydrochloride

Indexed keywords

ALKALINE PHOSPHATASE; BICARBONATE; CALCIUM; CALCIUM ACETATE; CALCIUM PHOSPHATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; SEVELAMER;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANOREXIA; ARTICLE; BICARBONATE BLOOD LEVEL; CALCIUM BLOOD LEVEL; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; LIPID BLOOD LEVEL; MALE; OPEN STUDY; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; PRESCHOOL CHILD; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SHORT COURSE THERAPY; TREATMENT OUTCOME;

ACETATES; CALCIUM COMPOUNDS; CHELATING AGENTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; POLYAMINES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 78751649829     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9688-9     Document Type: Article

References (30)

1. E Slatopolsky JA Delmez 1996 Pathogenesis of secondary hyperparathyroidism Nephrol Dial Transplant 11 Suppl 3 130 135 1:CAS:528:DyaK28Xlt1SnsbY%3D 8840328
2. National Kidney Foundation (NKF) 2003 K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 S1 S201
3. WN Suki R Zabaneh JL Cangiano J Reed D Fischer L Garett, et al. 2007 Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients Kidney Int 72 1130 1137 1:CAS:528:DC%2BD2sXhtFOksLbI 10.1038/sj.ki.5002466 17728707 (Pubitemid 47609037)
4. AG Clark A Oner G Ward C Turner S Rigden GB Haycock, et al. 1989 Safety and efficacy of calcium carbonate in children with chronic renal failure Nephrol Dial Transplant 4 539 544 1:STN:280:DyaK3c%2FhsFOktw%3D%3D 2507975
5. JW Coburn KC Norris HG Nebeker 1986 Osteomalacia and bone disease arising from aluminum Semin Nephrol 6 68 89 1:STN:280:DyaL2s3mt1Kgtg%3D%3D 3110896
6. F Eifinger F Wahn U Querfeld M Pollock A Gevargez P Kriener, et al. 2000 Coronary artery calcifications in children and young adults treated with renal replacement therapy Nephrol Dial Transplant 15 1892 1894 1:STN:280: DC%2BD3M%2FkvFKltg%3D%3D 10.1093/ndt/15.11.1892 11071992
7. GB Spasovski 2007 Bone health and vascular calcification relationships in chronic kidney disease Int Urol Nephrol 39 1209 1216 1:CAS:528: DC%2BD2sXhtlCntrnI 10.1007/s11255-007-9276-9 17899431 (Pubitemid 350193619)
8. DJ Goldsmith A Covic 2008 Calcium and the saga of the binders: accumulating controversy, or building consensus? Int Urol Nephrol 40 1009 10014 10.1007/s11255-008-9477-x 18836844
9. SL Burke EA Slatopolsky DI Goldberg 1997 Renagel, a novel calcium and aluminum free phosphate binder, inhibits phosphate absorption in normal volunteers Nephrol Dial Transplant 12 1640 1644 1:CAS:528:DyaK2sXlvV2ns74%3D 10.1093/ndt/12.8.1640 9269642 (Pubitemid 27346290)
10. GM Chertow SK Burke JM Lazarus K Stenzel D Wombolt D Goldberg, et al. 1997 Poly (allylamine hydrochloride) (Rena Gel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure Am J Kidney Dis 29 66 71 1:CAS:528:DyaK2sXnsVaksQ%3D%3D 10.1016/S0272-6386(97)90009-3 9002531
11. EA Slatopolsky SK Burke MA Dillon The Renagel Study Group 1999 RenaGel, a nonabsorbed calcium and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone Kidney Int 55 299 307 1:CAS:528:DyaK1MXjtVamtQ%3D%3D 10.1046/j.1523-1755.1999.00240.x 9893140 (Pubitemid 29004263)
12. H Mahdavi BD Kuizon B Gales HJ Wang RM Elashoff IB Salusky 2003 Sevelamer hydrochloride: an effective phosphate binder in dialyzed children Pediatr Nephrol 18 1260 1264 10.1007/s00467-003-1298-7 14586677 (Pubitemid 37527101)
13. National Kidney Foundation 2002 K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, stratification Am J Kidney Dis 39 S1 S266 10.1016/S0272-6386(02)70081-4
14. RichardA Sherman 2007 Dietary phosphate restriction and protein intake in dialysis patients. A misdirected focus Semin in Dialysis 20 16 18 10.1111/j.1525-139X.2007.00204.x
15. H Goldenberg A Fernandez 1996 Simplified method for the estimation of inorganic phosphorus in body fluids Clin Chem 12 871 882
16. Burtis CA, Ashwood ER (1998) Textbook of Clinical Chemistry, 3rd edn. Philadelphia, WB Saunders pp1917
17. DB Cottrell CS Frings 1979 Evaluation of the Beckman creatinine analyzer 2 Clin Biol Chem 12 159 161 1:STN:280:DyaL3c%2FptVequw%3D%3D
18. AW Lindall J Elting J Ells BA Roos 1999 Estimation of biologically active intact parathyroid hormone in normal and hyperparathyroid sera by sequential N-terminal immunoextraction and midregion radioimmunoassay J Clin Endocrinol Metab 57 1007 1014 10.1210/jcem-57-5-1007
19. K Schaefer J Scheer G Asmus E Umlauf J Hagemann D von Herrath 1991 The treatment of uraemic hyperphosphatemia with calcium acetate and calcium carbonate: a comparative study Nephrol Dial Transplant 61 70 75
20. J Connolly DC Harris 1995 Calcium acetate versus calcium carbonate in chronic hemodialysis Nephrology 1 47 50 10.1111/j.1440-1797.1995.tb00008.x
21. DI Goldberg MA Dillon EA Slatopolsky B Garrett JR Gray T Marbury M Weinberg D Wombolt SK Burke 1998 Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients Nephrol Dial Transplant 13 2303 2310 1:CAS:528:DyaK1cXmsVCgs7o%3D 10.1093/ndt/13.9.2303 9761513 (Pubitemid 28416557)
22. GM Chertow M Dillon SK Burke M Steg AJ Bleyer BN Garrett DT Domoto BM Wikes DG Wombolt EA Slatopolsky 1999 A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients Clin Nephrol 51 18 26 1:CAS:528:DyaK1MXjsFektg%3D%3D 9988142
23. AK Pieper D Haffner B Hoppe K Dittrich G Offner KE Bonzel U John S Fründ G Klaus A Stübinger G Düker U Querfeld 2006 A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD Am J Kidney Dis 47 625 635 1:CAS:528:DC%2BD28XkvVantrk%3D 10.1053/j.ajkd.2005.12. 039 16564940
24. WY Qunibi RE Hootkins LL McDowell MS Meyer M Simon R Garza, et al. 2004 Treatment of hyperphosphatemia in hemodialysis patients: the Calcium Acetate Renagel Evaluation (CARE study) Kidney Int 65 1914 1926 1:CAS:528: DC%2BD2cXktl2gtbk%3D 10.1111/j.1523-1755.2004.00590.x 15086935 (Pubitemid 38591044)
25. GA Block P Raggi A Bellasi L Kooienga DM Spiegel 2007 Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients Kidney Int 71 1 4 10.1038/sj.ki.5002059
26. SB Arnaud RS Goldsmith PW Lambert VL Go 1975 25-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man Exp Biol Med 149 570 572 1:CAS:528:DyaE2MXkslKhsrg%3D
27. MP Paz Marco S Muray A Betriu L Craver M Belart E Fernandez 2002 Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients Nephron 92 499 500 10.1159/000063307 (Pubitemid 35316909)
28. AB Pai BM Shepler 2009 Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications Pharmacotherapy 29 554 561 1:CAS:528:DC%2BD1MXhtVGitr7P 10.1592/phco.29.5.554 19397463
29. MJ Landray J Thambyrajah FJ Mc Glynn 2001 Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment Am J Kidney Dis 38 537 546 1:STN:280:DC%2BD3MvovFKgtQ%3D%3D 10.1053/ajkd.2001.26850 11532686
30. M Tonelli N Wiebe B Culleton H Lee S Klarenbach F Shrive, et al. 2007 Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients Nephrol Dial Transplant 22 2856 2866 1:CAS:528:DC%2BD2sXhtFWhtbnE 10.1093/ndt/gfm421 17906326 (for the Alberta Kidney Disease Network) (Pubitemid 350093462)